Question: Medzyme Pharmaceuticals has maintained a 50-50 D-E mix for capital investments. Equity capital has cost 11%; however, debt capital that historically cost 9% has now
Medzyme Pharmaceuticals has maintained a 50-50 D-E mix for capital investments. Equity capital has cost 11%; however, debt capital that historically cost 9% has now increased by 20% per year. If Medzyme does not want to exceed its historical weighted average cost of capital (WACC), and it is forced to go to a D-E mix of 75–25, the maximum acceptable cost of equity capital is closest to:
(a) 7.6%
(b) 9.2%
(c) 9.8%
(d) 10.9%
Step by Step Solution
3.54 Rating (168 Votes )
There are 3 Steps involved in it
Calculate historical WACC 05 11 05 9 10 S... View full answer
Get step-by-step solutions from verified subject matter experts
Document Format (1 attachment)
217-B-E-M (1373).docx
120 KBs Word File
